文献速递系统性红斑狼疮其他结缔组织病

超声识别对治疗反应最佳的伴肌肉骨骼症状的系统性红斑狼疮患者

Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

这项纵向多中心研究纳入133例伴医生诊断炎症性关节痛的SLE患者,单次肌注甲泼尼龙120 mg后随访6周,比较超声阳性与阴性者的临床反应。全分析集未达主要终点,但排除32例纤维肌痛患者后,超声阳性者第2周晨僵VAS改善显著更优,且BILAG和SLEDAI反应更高。

要点

  • SLE伴炎症性关节痛患者中超声阳性者占多数,但仅68%有肿胀关节。
  • 全分析集未达主要终点,排除纤维肌痛后超声阳性者治疗反应更优。
  • 影像学检测的滑膜炎/腱鞘炎可用于治疗决策和临床试验富集。

核心结论

  • 在无纤维肌痛的SLE患者中,基线超声阳性者接受甲泼尼龙治疗后临床反应更好。

研究设计与样本

  • 纵向多中心研究,133例伴医生诊断炎症性关节痛的SLE患者接受单次肌注甲泼尼龙120 mg,随访6周。

主要发现

  • 133例中78例超声阳性,其中仅53例(68%)有一个或以上肿胀关节。
  • 66例有一个或以上肿胀关节的患者中20%超声阴性。
  • 超声阳性与关节肿胀、对称性小关节分布和血清学相关。
  • 全分析集(N=133)第2周基线校正晨僵VAS差异为-7.7 mm(95%CI -19.0, 3.5),P=0.178。
  • 排除32例纤维肌痛后,超声阳性者第2周基线校正晨僵VAS差异为-12.1 mm(95%CI -22.2, -0.1),P=0.049;校正治疗后为-12.8 mm(95%CI -22, -3),P=0.007。

关键数值与推荐

  • 超声阳性定义为灰阶≥2和/或能量多普勒≥1。
  • 主要终点为第2周晨僵VAS,校正基线后比较超声阳性与阴性患者。

临床怎么用

  • 对伴炎症性关节痛的SLE患者,可考虑超声检测滑膜炎/腱鞘炎以辅助治疗决策。
  • 超声阳性者可能从糖皮质激素治疗中获益更多,尤其需注意排除纤维肌痛。

局限性

  • 原文未报告局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine whether SLE patients with inflammatory joint symptoms and US synovitis/tenosyovitis achieve better clinical responses to glucocorticoids compared with patients with normal scans. Secondary objectives included identification of clinical features predicting US synovitis/tenosynovitis. METHODS: In a longitudinal multicentre study, SLE patients with physician-diagnosed inflammatory joint pain received intramuscular methylprednisolone 120 mg once. Clinical assessments, patient-reported outcomes and bilateral hand/wrist USs were collected at 0, 2 and 6 weeks. The primary outcome (determined via internal pilot) was the early morning stiffness visual analogue scale (EMS-VAS) at 2 weeks, adjusted for baseline, comparing patients with positive (greyscale ≥2 and/or power Doppler ≥1) and negative US. Post hoc analyses excluded FM. RESULTS: Of 133 patients, 78 had a positive US. Only 53 (68%) of these had one or more swollen joint. Of 66 patients with one or more swollen joint, 20% had a negative US. A positive US was associated with joint swelling, symmetrical small joint distribution and serology. The primary endpoint was not met: in the full analysis set (N = 133) there was no difference in baseline-adjusted EMS-VAS at week 2 [-7.7 mm (95% CI -19.0, 3.5); P = 0.178]. After excluding 32 patients with FM, response was significantly better in patients with a positive US at baseline [baseline-adjusted EMS-VAS at 2 weeks -12.1 mm (95% CI -22.2, -0.1); P = 0.049]. This difference was greater when adjusted for treatment [-12.8 mm (95% CI -22, -3); P = 0.007]. BILAG and SLEDAI responses were higher in US-positive patients. CONCLUSION: In SLE patients without FM, those with a positive US had a better clinical response to therapy. Imaging-detected synovitis/tenosynovitis may be considered to decide on therapy and enrich clinical trials.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Mahmoud K, Zayat AS, Yusof MYM, et al. Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology (Oxford). 2021. PMID: 33792659. doi:10.1093/rheumatology/keab288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。